GlassScriptPhysician profile
William L Nabors
NPI 1982614459
$1,260.72
in general payments reported to CMS, 2019-2025
23 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $423 · 2020: $90.07 · 2021: $103 · 2022: $245 · 2023: $159 · 2024: $118 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $489.09 | 2019-2025 | Xtandi, Myrbetriq |
| Blue Earth Diagnostics | $154.66 | 2019-2022 | |
| Medtronic, INC. | $70.79 | 2022 | |
| Abbvie INC. | $54.63 | 2019-2022 | |
| Endo USA, INC. | $51.66 | 2024 | Aveed, Xiaflex |
| Endo Pharmaceuticals INC. | $47.14 | 2023 | Xiaflex, Aveed |
| C. R. Bard, INC. & Subsidiaries | $40.80 | 2022-2025 | Bard Urinary Drainage Bag |
| Olympus America INC. | $30.65 | 2024-2025 | Itind System |
| Zyla Life Sciences, INC. | $29.58 | 2019 | |
| Sumitomo Pharma America, INC. | $28.36 | 2023 | Gemtesa |
| Boston Scientific Corporation | $28.32 | 2022-2024 | Greenlight Xps |
| Urovant Sciences INC | $27.77 | 2022 | |
| Coloplast Corp | $27.72 | 2019-2024 | |
| Tempus Ai, INC | $23.65 | 2025 | Xt Cdx |
| Civco Medical Instruments | $23.39 | 2024 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $19.95 | 2023 | |
| Karl Storz Endoscopy-America | $18.84 | 2023 | |
| Tolmar, INC. | $17.16 | 2023 | |
| Dentsply Ih Ab | $16.85 | 2025 | Lofric |
| Profound Medical Corp. | $16.49 | 2025 | Tulsa-Pro |
| Ferring Pharmaceuticals INC. | $16.46 | 2019 | |
| Travere Therapeutics, INC. | $13.95 | 2020-2021 | |
| Richard Wolf Medical Instruments Corp. | $12.81 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Nabors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.